Our goal is to provide family peace of mind and confidence with a single blood sample analysis, backed by the science-based and technology-intensive NIPTIFY Focus Plus test.
Address
Address
Phone
Phone
+372 733 0403
The NIPTIFY team
The NIPTIFY team
The NIPTIFY team includes the outstanding and renowned researchers – four members have a doctorate, one has a doctor of medicine, and multiple has a master’s degree. Together, the team members have published over 250 scientific articles and hold several patents. In international cooperation, the tight collaboration is with the University of Helsinki, the Karolinska Institute, and the Catholic University of Leuven in Belgium. The team members have established companies professionally and won the Swedish business award “Innovation of the Year” in 2016.
We aim to participate in focused research, develop methodologies and develop precision medicine and personalized medicine tests needed in women’s and infertility treatment clinics. The success story of the NIPTIFY test is one of the reasons why the Health Insurance Fund started reimbursing the NIPT test in January 2020. Thus, NIPTIFY has significantly contributed to the quality of national first-trimester screening. Tervise-TAK offers medical services based on the Health Board’s license L05235. The NIPTIFY medical laboratory meets the requirements of EVS-EN ISO 15189:2021. The NIPTIFY test is a CE-IVD-marked in vitro diagnostic device that has been validated, controlled, and can provide in the European Union.